Newsroom

Newsroom

Novel Metrics of HER2 Heterogeneity in HER2-Positive and HER2-Low Breast Cancer via High Dimensional Multiplexed Immunofluorescence Spatial Profiling

Literature
Read More

Examining RET Fusions

Literature
Read More

Paroxysmal Nocturnal Hemoglobinuria

Literature
Read More

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

Press Release
Read More

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Literature
Read More

NeoGenomics Honored with Platinum Design Award for the NeoAccess Technology Platform

Blog
Read More

SITC Overview 2023

Blog
Read More

A Novel Lab Developed Test Simultaneously Assays Heme and Solid Tumors and Shows Good Performance on Degraded Samples at Low Minimum Input

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients